Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Bloomston

Showing results (111-120 of 189) with videos related to

Pageof 19
Sort By:
Annals of Surgical Oncology|November 1, 2014
Neoadjuvant modified (m) FOLFIRINOX for locally advanced unresectable (LAPC) and borderline resectable (BRPC) adenocarcinoma of the pancreasMarlo Blazer, Christina Wu, Richard M Goldberg, et al.
Journal of Surgical Oncology|May 22, 2014
Multi-institutional analysis of recurrence and survival after hepatectomy for fibrolamellar carcinomaRyan T Groeschl, John T Miura, Ray K Wong, et al.
Journal of Surgical Oncology|October 31, 2018
Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastasesJeffery Chakedis, Eliza W Beal, Steven Sun, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 11, 2014
Outcomes in patients with obstructive jaundice from metastatic colorectal cancer and implications for managementShawnn D Nichols, Scott Albert, Lawrence Shirley, et al.
General Thoracic and Cardiovascular Surgery|June 16, 2011
Atrial fibrillation after esophagectomy: an indicator of postoperative morbidityStanislaw P A Stawicki, Mark P Prosciak, Anthony T Gerlach, et al.
Endocrine-Related Cancer|July 20, 2007
Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor-alpha, CH11 and CYC202Manali Mody, Nachiket Dharker, Mark Bloomston, et al.
Carcinogenesis|June 1, 2014
Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cellsI-Lu Lai, Chih-Chien Chou, Po-Ting Lai, et al.
Carcinogenesis|April 30, 2019
Retraction: Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cellsI-Lu Lai, Chih-Chien Chou, Po-Ting Lai, et al.
Cancer Research|March 22, 2013
Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent mannerThomas A Mace, Zeenath Ameen, Amy Collins, et al.
World Journal of Surgical Oncology|July 20, 2007
Combined use of preoperative 18F FDG-PET imaging and intraoperative gamma probe detection for accurate assessment of tumor recurrence in patients with colorectal cancerIsmet Sarikaya, Stephen P Povoski, Osama H Al-Saif, et al.
Pageof 19

Showing results (111-120 of 189) with videos related to

Sort By:
Pageof 19
Annals of Surgical Oncology|November 1, 2014
Neoadjuvant modified (m) FOLFIRINOX for locally advanced unresectable (LAPC) and borderline resectable (BRPC) adenocarcinoma of the pancreasMarlo Blazer, Christina Wu, Richard M Goldberg, et al.
Journal of Surgical Oncology|May 22, 2014
Multi-institutional analysis of recurrence and survival after hepatectomy for fibrolamellar carcinomaRyan T Groeschl, John T Miura, Ray K Wong, et al.
Journal of Surgical Oncology|October 31, 2018
Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastasesJeffery Chakedis, Eliza W Beal, Steven Sun, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 11, 2014
Outcomes in patients with obstructive jaundice from metastatic colorectal cancer and implications for managementShawnn D Nichols, Scott Albert, Lawrence Shirley, et al.
General Thoracic and Cardiovascular Surgery|June 16, 2011
Atrial fibrillation after esophagectomy: an indicator of postoperative morbidityStanislaw P A Stawicki, Mark P Prosciak, Anthony T Gerlach, et al.
Endocrine-Related Cancer|July 20, 2007
Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor-alpha, CH11 and CYC202Manali Mody, Nachiket Dharker, Mark Bloomston, et al.
Carcinogenesis|June 1, 2014
Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cellsI-Lu Lai, Chih-Chien Chou, Po-Ting Lai, et al.
Carcinogenesis|April 30, 2019
Retraction: Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cellsI-Lu Lai, Chih-Chien Chou, Po-Ting Lai, et al.
Cancer Research|March 22, 2013
Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent mannerThomas A Mace, Zeenath Ameen, Amy Collins, et al.
World Journal of Surgical Oncology|July 20, 2007
Combined use of preoperative 18F FDG-PET imaging and intraoperative gamma probe detection for accurate assessment of tumor recurrence in patients with colorectal cancerIsmet Sarikaya, Stephen P Povoski, Osama H Al-Saif, et al.
Pageof 19